# The Effect of Glucagon Like Peptide (GLP)-1 in Psoriasis

> **NCT01460069** · NA · COMPLETED · sponsor: **Annesofie Faurschou** · enrollment: 20 (estimated)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** liraglutide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01460069
- **Lead sponsor:** Annesofie Faurschou
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2013-06-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01460069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01460069, "The Effect of Glucagon Like Peptide (GLP)-1 in Psoriasis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01460069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*